BSCL2 Gene SPG17 Genetic Test
Components:
- Test Name: BSCL2 Gene SPG17 Genetic Test
- Price: 4400.0 AED
Sample Condition:
Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery:
3 to 4 Weeks
Method:
NGS Technology
Test Type:
Neurological Disorders
Doctor:
Neurologist
Test Department:
Genetics
Pre Test Information:
Clinical History of Patient who is going for BSCL2 Gene SPG17 NGS Genetic DNA Test
A Genetic Counselling session to draw a pedigree chart of family members affected with BSCL2 Gene SPG17
Test Details:
The BSCL2 gene, also known as SPG17, is responsible for producing a protein called seipin. Mutations in the BSCL2 gene can lead to a rare neurological disorder called spastic paraplegia type 17 (SPG17) or Silver syndrome.
NGS (Next-Generation Sequencing) genetic testing is a method used to analyze the DNA sequence of a gene. It can identify mutations or variations in the BSCL2 gene that may be associated with SPG17. NGS testing is a powerful tool that allows for the analysis of multiple genes simultaneously, providing a comprehensive evaluation of an individual’s genetic makeup.
Genetic testing for SPG17 can be done through a blood or saliva sample. The sample is sent to a laboratory where the DNA is extracted and analyzed using NGS technology. The results of the test can help diagnose SPG17 and provide information about the specific mutation present in the BSCL2 gene.
Genetic testing for SPG17 can be useful for individuals who have symptoms consistent with the disorder, as well as for family members of affected individuals who may be at risk of inheriting the mutation. It can also be used for carrier testing in individuals with a family history of SPG17, to determine if they carry a mutation in the BSCL2 gene.
It is important to note that genetic testing for SPG17 is typically ordered by a healthcare professional, such as a geneticist or neurologist, who can interpret the results and provide appropriate counseling and guidance.
| Test Name | BSCL2 Gene SPG17 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Neurological Disorders |
| Doctor | Neurologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for BSCL2 Gene SPG17 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with BSCL2 Gene SPG17 |
| Test Details |
The BSCL2 gene, also known as SPG17, is responsible for producing a protein called seipin. Mutations in the BSCL2 gene can lead to a rare neurological disorder called spastic paraplegia type 17 (SPG17) or Silver syndrome. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze the DNA sequence of a gene. It can identify mutations or variations in the BSCL2 gene that may be associated with SPG17. NGS testing is a powerful tool that allows for the analysis of multiple genes simultaneously, providing a comprehensive evaluation of an individual’s genetic makeup. Genetic testing for SPG17 can be done through a blood or saliva sample. The sample is sent to a laboratory where the DNA is extracted and analyzed using NGS technology. The results of the test can help diagnose SPG17 and provide information about the specific mutation present in the BSCL2 gene. Genetic testing for SPG17 can be useful for individuals who have symptoms consistent with the disorder, as well as for family members of affected individuals who may be at risk of inheriting the mutation. It can also be used for carrier testing in individuals with a family history of SPG17, to determine if they carry a mutation in the BSCL2 gene. It is important to note that genetic testing for SPG17 is typically ordered by a healthcare professional, such as a geneticist or neurologist, who can interpret the results and provide appropriate counseling and guidance. |
